Pinterest Inc vs Twist Bioscience Corp — how do they compare? Pinterest Inc trades at $18.42 (market cap $11.41B), while Twist Bioscience Corp trades at $125.52 (market cap $8.42B). The key difference: Pinterest Inc is the larger of the two by market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals.
| PINS | TWST | |
|---|---|---|
Market Cap | $11.41B | $8.42B |
Sector | Media | Health |
52-Week High | $36.49 | $153.10 |
52-Week Low | $15.42 | $24.16 |
Enterprise Value | $11.33B | $8.35B |
Signals from Pluang's Aura AI — not financial advice
Pinterest (PINS) trades at $20.14, down 1.27% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth from $2.8B in 2022 to $4.2B in 2025, though net income margin compressed to 5.46%. Recent CFO resignation and insider selling have weighed on sentiment, while analyst consensus remains bullish with a $28.69 price target representing 42% upside potential.
PINS offers significant upside based on analyst targets but faces near-term headwinds from leadership transition and competitive pressures. The stock's high P/E ratio of 59.24 requires continued execution on AI-driven growth initiatives. Key risks include market share competition and the company's ability to monetize international users effectively while managing rising infrastructure costs from the $4B AWS partnership.
Twist Bioscience (TWST) trades at $128.06, up 2.68% today, but remains below the analyst consensus price target of $106.14. The stock shows mixed technical signals with bearish overall momentum but bullish moving averages. Fundamentally, the company continues to report losses with a net income margin of -31.66% despite 23% revenue growth in Q3 2026. Recent news highlights AI-driven optimism and institutional buying interest.
TWST presents a high-risk growth story with strong analyst support (79% buy ratings) but persistent profitability challenges. The stock's valuation appears stretched with P/S of 18.09 and P/B of 18.89. Key catalysts include AI drug discovery partnerships and path to EBITDA breakeven, while risks include cash burn and competitive pressures in biotech.
Trailing returns across standard periods
Latest headlines on both assets
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →